Kenneth Gordon to Arthritis, Juvenile
This is a "connection" page, showing publications Kenneth Gordon has written about Arthritis, Juvenile.
Connection Strength
0.049
-
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease. Ann Rheum Dis. 2013 Apr; 72(4):517-24.
Score: 0.025
-
Clinical trial safety and mortality analyses in patients receiving etanercept across approved indications. J Drugs Dermatol. 2011 Mar; 10(3):289-300.
Score: 0.023